NASA Announces 'Mother Lode' of New Planets: 715

Our galaxy is looking far more crowded and hospitable. NASA on Wednesday confirmed a bonanza of 715 newly discovered planets outside our solar system.

Scientists using the planet-hunting Kepler telescope pushed the number of planets discovered in the galaxy to about 1,700. Twenty years ago, astronomers had not found any planets circling stars other than the ones revolving around our sun.

"We almost doubled just today the number of planets known to humanity," NASA planetary scientist Jack Lissauer said in a Wednesday teleconference, calling it "the big mother lode."

Astronomers used a new confirmation technique to come up with the largest single announcement of a batch of exoplanets what planets outside our solar system are called.

While Wednesday's announcements were about big numbers, they also were about implications for life behind those big numbers.

All the new planets are in systems like ours where multiple planets circle a star. The 715 planets came from looking at just 305 stars. They were nearly all in size closer to Earth than gigantic Jupiter.

And four of those new exoplanets orbit their stars in "habitable zones" where it is not too hot or not too cold for liquid water which is crucial for life to exist.

Douglas Hudgins, NASA's exoplanet exploration program scientist, called Wednesday's announcement a major step toward Kepler's ultimate goal: "finding Earth 2.0."

It's a big step in not just finding other Earths, but "the possibility of life elsewhere," said Lisa Kaltenegger, a Harvard and Max Planck Institute astronomer who wasn't part of the discovery team.

The four new habitable zone planets are all at least twice as big as Earth so that makes them more likely to be gas planets instead of rocky ones like Earth and less likely to harbor life.

See more here:

NASA Announces 'Mother Lode' of New Planets: 715

NASA announces planetary bonanza, discovery of 715 new worlds

WASHINGTON, Feb. 26 (UPI) -- NASA says its Kepler space telescope has delivered another bonanza of distant planets, finding 715 new worlds orbiting 305 distant stars.

Many of the discoveries are of multiple-planet systems much like our own solar system, the space agency said Wednesday.

Nearly 95 percent of these planets are smaller than Neptune, a significant increase in the number of known small-sized planets more akin to Earth than previously identified exoplanets outside our solar system, NASA officials said.

"The Kepler team continues to amaze and excite us with their planet hunting results," said John Grunsfeld, associate administrator for NASA's Science Mission Directorate in Washington. "That these new planets and solar systems look somewhat like our own, portends a great future when we have the James Webb Space Telescope in space to characterize the new worlds."

Kepler observed hundreds of stars that have multiple planet candidates to verify the 715 new worlds, NASA said.

"Four years ago, Kepler began a string of announcements of first hundreds, then thousands, of planet candidates -- but they were only candidate worlds," said Jack Lissauer, planetary scientist at NASA's Ames Research Center in Moffett Field, Calif. who led the research team. ""We've now developed a process to verify multiple-planet candidates in bulk to deliver planets wholesale, and have used it to unveil a veritable bonanza of new worlds."

The latest discoveries bring the confirmed count of planets outside our solar system to nearly 1,700, NASA said.

Read the original post:

NASA announces planetary bonanza, discovery of 715 new worlds

NASA, California in partnership to respond to ongoing drought

WASHINGTON, Feb. 25 (UPI) -- NASA says it is partnering with California to develop technologies to better manage and monitor the state's water resources and respond to its ongoing drought.

NASA scientists would work with California Department of Water Resources water managers, university researchers and other state resource management agencies to apply advanced remote sensing and improved forecast modeling to better assess water resources, monitor drought conditions and water supplies, plan for drought response and mitigation, and measure drought impacts, the space agency reported Tuesday.

"Over the past two decades, NASA has developed capabilities to measure and provide useful information for all components of Earth's freshwater resources worldwide," Michael Freilich, director of NASA's Earth Science Division in Washington, said. "Working with partners like DWR, we are leveraging NASA's unique Earth monitoring tools and science expertise to help managers address the state's water management challenges."

California Gov. Edmund G. Brown Jr. has declared a drought state of emergency and directed state officials to take all necessary actions to prepare for water shortages in 2014.

Officials said they welcomed a chance to work with NASA.

"We value the partnership with NASA and the ability of their remote sensing resources to integrate data over large spatial scales, which is useful for assessing drought impacts," Jeanine Jones, DWR Interstate Water Resources Manager, said.

More here:

NASA, California in partnership to respond to ongoing drought

NASA announces "mother lode" of 715 newly discovered planets

WASHINGTON NASA on Wednesday confirmed a bonanza of 715 newly discovered planets outside our solar system. Scientists using the planet-hunting Kepler telescope pushed the number of planets discovered in the galaxy to about 1,700. Twenty years ago, astronomers had not found any planets circling stars other than the ones revolving around our sun.

"We almost doubled just today the number of planets known to humanity," said NASA planetary scientist Jack Lissauer in a teleconference, calling it "the big mother lode."

Although Wednesday's announcements were about big numbers, they also were about implications for life behind those big numbers.

The new planets are in systems like ours where multiple planets circle a star. The 715 planets came from looking at just 305 stars. They were nearly all in size closer to Earth than gigantic Jupiter. Four of those exoplanets orbit their stars in "habitable zones" where it is not too hot or not too cold for liquid water, which is crucial for life to exist.

Read the original here:

NASA announces "mother lode" of 715 newly discovered planets

Global Microscopes Market to Reach USD 7,343.7 Million by 2020 According to a New Market Study by Grand View Research …

San Francisco, California (PRWEB) February 26, 2014

The global market for microscopes is expected to reach USD 7,343.7 million by 2020, according to a new study by Grand View Research, Inc. Growing private and government support for nanotechnology R&D is expected to have a positive impact on microscope demand over the next six years. In addition, growing demand for advanced and high resolution microscopes such as super resolution microscopes for conducting R&D exercises in the fields of life sciences and nanotechnology is also expected to have a positive impact on demand over the forecast period.

Emergence of new application areas such as quantum dots and miniature transistor chips will serve this market as future growth opportunities. Quantum dots technology is currently in a nascent stage and is expected to cater to multiple application areas such as in transistors, diode lasers, quantum computing, biological imaging, solid-state lighting, electroluminescent displays and photo-voltaic cells. Optical microscopes dominated the market in 2012, accounting for over 39% of total revenue, primarily owing to their large application base. However, due to rising adoption rates of advanced microscopes, scanning probe microscopes and electron microscopes are expected to gain market share over the next six years. Scanning probe microscopes are expected to be the fastest growing product segment, at an estimated CAGR of 18.0% from 2014 to 2020. Features such as non dependence on wavelength of the source light, resolving atoms and generating better 3D maps of surfaces are some of the factors expected to increase market penetration for these products.

The report Microscopes Market Analysis and Segment Forecasts to 2020, is available now to Grand View Research customers at http://www.grandviewresearch.com/industry-analysis/Microscopes-Industry

Further Key findings from the study suggest:

Direct Link for Sample Request of this Report - http://www.grandviewresearch.com/request/56

For the purpose of this study, Grand View Research has segmented the global microscopes market on the basis of product, application and region:

Browse All Reports of Healthcare Category @ http://www.grandviewresearch.com/industry/healthcare

About Grand View Research

Grand View Research, Inc. is a market research and consulting company that provides off-the-shelf, customized research reports and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and energy. With a deep-seated understanding of varied business environments, Grand View Research provides strategic objective insights. For more information, visit - Grand View Research

Read more:

Global Microscopes Market to Reach USD 7,343.7 Million by 2020 According to a New Market Study by Grand View Research ...

Oil spill cleanup by sponge: Wisconsin scientists tout tidy technology

MILWAUKEE In a development arising from nanotechnology research, scientists in Madison, Wis., have created a spongelike material that could provide a novel and sustainable way to clean up oil spills.

Its known as an aerogel, but it could just as well be called a smart sponge.

To demonstrate how it works, researchers add a small amount of red dye to diesel, making the fuel stand out in a glass of water. The aerogel is dipped in the glass and within minutes, the sponge has soaked up the diesel. The aerogel is now red, and the glass of water is clear.

It was very effective, said Shaoqin Sarah Gong, who runs a biotechnology-nanotechnology lab at the Wisconsin Institute for Discovery in Madison.

So if you had an oil spill, for example, the idea is you could throw this aerogel sheet in the water and it would start to absorb the oil very quickly and efficiently, said Gong, a University of Wisconsin-Madison associate professor of biomedical engineering. Once its fully saturated, you can take it out and squeeze out all the oil.

The materials absorbing capacity is reduced somewhat after each use, but the product can be reused for a couple of cycles, Gong said.

Researchers in Madison have patented their aerogel technology and are now seeking paper or petroleum industry partners to collaborate or fund research to test it on a larger scale.

Details of the aerogel discovery were published last month in the Journal of Materials Chemistry A. Researchers say the product has the potential to help reduce water pollution that leads to water shortages around the world.

The aerogel absorption technology is the result of a collaboration between the Wisconsin Institute for Discovery and a nanotechnology pilot plant established two years ago at the U.S. Department of Agricultures Forest Products Lab in Madison.

At the nanotech lab, researchers are working to develop new uses for wood that could provide a boon to Wisconsins paper industry by finding new markets for forest products.

Visit link:

Oil spill cleanup by sponge: Wisconsin scientists tout tidy technology

global nano medicine market – Research Papers – Inwithabhi

Brochure More information from http://www.researchandmarkets.com/reports/2617729/

Global Nanomedicine Market 2012-2016 Description:

The analysts forecast the Global Nanomedicine market to grow at a CAGR of 12.57 percent over the period 2012-2016. One of the key factors contributing to this market growth is the emergence of nanorobotics. The Global Nanomedicine market has also been witnessing the increasing use of novel nanomaterials. However, lengthy approval procedures could pose a challenge to the growth of this market. The report, the Global Nanomedicine Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market in the Americas, and the EMEA and APAC regions; it also covers the Global Nanomedicine market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. The key vendors dominating this space include Abbott Laboratories, AstraZeneca plc, Bristol-Myers Squibb Co., Celgene Corp., GlaxoSmithKline plc, and Pfizer Inc. The other vendors mentioned in this report are Ablynx NV, Acusphere Inc., Aphios Corp., Arrowhead Research Corp., BioForce, Nanosciences Holdings Inc., Bio-Gate AG, Biophan Technologies Inc., BioSante Pharmaceuticals Inc., CombiMatrix Corp., Enzon Pharmaceuticals Inc., GE Healthcare Ltd., Gilead Sciences Inc., IDEX Corp., IGI Laboratories Inc., Kereos Inc., Kimberly-Clark Corp., MIV Therapeutics Inc., Nanobiotix S.A., NanoCarrier Co. Ltd., Nanogen Inc., NanoLogix Inc., NanoMed Pharmaceuticals Inc., Nanotherapeutics Inc., NanoViricides Inc., Paladin Labs Inc., pSivida Corp., Qiagen N.V., Roche Holding AG, Skyepharma PLC, Smith & Nephew plc, Starpharma Holdings Ltd., Stryker Corp., and Tecan Group Ltd. Key questions answered in this report: - What will the market size be in 2016 and what will be the growth rate? - What are key market trends? - What is driving... [continues]

Read full essay

(2014, 02). global nano medicine market. StudyMode.com. Retrieved 02, 2014, from http://www.studymode.com/essays/Global-Nano-Medicine-Market-47972370.html

"global nano medicine market" StudyMode.com. 02 2014. 2014. 02 2014 <http://www.studymode.com/essays/Global-Nano-Medicine-Market-47972370.html>.

"global nano medicine market." StudyMode.com. StudyMode.com, 02 2014. Web. 02 2014. <http://www.studymode.com/essays/Global-Nano-Medicine-Market-47972370.html>.

"global nano medicine market." StudyMode.com. 02, 2014. Accessed 02, 2014. http://www.studymode.com/essays/Global-Nano-Medicine-Market-47972370.html.

View original post here:

global nano medicine market - Research Papers - Inwithabhi

Magnetic Medicine: Nanoparticles target cancer-fighting immune cells

Using tiny particles designed to target cancer-fighting immune cells, Johns Hopkins researchers have trained the immune systems of mice to fight melanoma, a deadly skin cancer. The experiments, described on the website of ACS Nano on February 24, represent a significant step toward using nanoparticles and magnetism to treat a variety of conditions, the researchers say.

"Size was key to this experiment," says Jonathan Schneck, M.D., Ph.D., a professor of pathology, medicine and oncology at the Johns Hopkins University School of Medicine's Institute for Cell Engineering. "By using small enough particles, we could, for the first time, see a key difference in cancer-fighting cells, and we harnessed that knowledge to enhance the immune attack on cancer."

Schneck's team has pioneered the development of artificial white blood cells, so-called artificial antigen-presenting cells (aAPCs), which show promise in training animals' immune systems to fight diseases such as cancer. To do that, the aAPCs must interact with immune cells known as naive T cells that are already present in the body, awaiting instructions about which specific invader they will battle. The aAPCs bind to specialized receptors on the T cells' surfaces and "presenting" them with distinctive proteins called antigens. This process activates the T cells, programming them to battle a specific threat such as a virus, bacteria or tumor, as well as to make more T cells.

The team had been working with microscale particles, which are about one-hundredth of a millimeter across. But, says Schneck, aAPCs of that size are still too large to get into some areas of a body and may even cause tissue damage because of their relatively large size. In addition, the microscale particles bound equally well to naive T cells and others, so the team began to explore using much smaller nanoscale aAPCs. Since size and shape are central to how aAPCs interact with T cells, Karlo Perica, a graduate student in Schneck's laboratory, tested the impact of these smaller particles.

The so-called nano-aAPCs were small enough that many of them could bind to a single T cell, as the team had expected. But when Perica compared naive T cells to those that had been activated, he found that the naive cells were able to bind more nanoparticles. "This was quite surprising, since many studies had already shown that naive and activated T cells had equal numbers of receptors," Schneck says. "Based on Karlo's results, we suspected that the activated cells' receptors were configured in a way that limited the number of nanoparticles that could bind to them."

To see whether there indeed was a relationship between activation and receptor clustering, Perica applied a magnetic field to the cells, causing the nano-aAPCs to attract one another and cluster together, bringing the receptors with them. The clustering did indeed activate the naive T cells, and it made the activated cells even more active -- effectively ramping up the normal immune response.

To examine how the increased activation would play out in living animals, the team treated a sample of T cells with nano-aAPCs targeting those T cells programmed to battle melanoma. The researchers next put the treated cells under a magnetic field and then put them into mice with skin tumors. The tumors in mice treated with both nano-aAPCs and magnetism stopped growing, and by the end of the experiment, they were about 10 times smaller than those of untreated mice, the researchers found. In addition, they report, six of the eight magnetism-treated mice survived for more than four weeks showing no signs of tumor growth, compared to zero of the untreated mice.

"We were able to fine-tune the strength of the immune response by varying the strength of the magnetic field and how long it was applied, much as different doses of a drug yield different effects," says Perica. "We think this is the first time magnetic fields have acted like medicine in this way."

In addition to its potential medical applications, Perica notes that combining nanoparticles and magnetism may give researchers a new window into fundamental biological processes. "In my field, immunology, a major puzzle is how T cells pick out the antigen they're targeting in a sea of similar antigens in order to find and destroy a specific threat," he says. "Receptors are key to that action, and the nano-aAPCs let us detect what the receptors are doing."

"We have a bevy of new questions to work on now: What's the optimal magnetic 'dose'? Could we use magnetic fields to activate T cells without taking them out of the body? And could magnets be used to target an immune response to a particular part of the body, such as a tumor's location?" Schneck adds. "We're excited to see where this new avenue of research takes us."

The rest is here:

Magnetic Medicine: Nanoparticles target cancer-fighting immune cells

Postgame Franscript: Coach talks Minnesota loss

Heres a transcript of Fran McCafferys postgame news conference. The questions are paraphrased but the quotes are direct.

How would you describe the defense right now?

We need some work, and well keep working on it.

Is the defensive performance puzzling because of the strides youve made?

I think we played against a team that was inspired that was really working, sharing the ball. They have good shooters. They havent been shooting well. It doesnt mean theyre not good shooters. Austin Hollins has always been a good shooter. Hes been off. (Malik) Smith has been off. They have a lot of guys who have been off. Tonight they were making them.

What specifically do you need to work on?

I think we just have to stay in our stance, stay engaged, stay after them. Whether its ball screens or drive and kicks or transition defense. It came easy for us early; we were up nine and we didnt lock in defensively then like I think we should have. All the sudden you look and youre down 10.

Now they were on fire. I get that and the crowd got into it and stuff. Youve got to adjust when (Charles) Buggs is hitting or (Austin) Hollins is hitting. They were on fire in the first half. I dont know that Ive coached against a team that made nine in a half. But this team has the potential to do that. Theyre a good 3-point shooting team.

How much of it was not getting back in transition or do you just tip your cap to your opponent?

The rest is here:

Postgame Franscript: Coach talks Minnesota loss

Clinical Genetics and Epigenetics: Precision Medicine for Age Management by Florence Comite, MD – Video


Clinical Genetics and Epigenetics: Precision Medicine for Age Management by Florence Comite, MD
This is a preview of a lecture given at the 2013 Age Management Medicine Conference in Las Vegas. The full lecture with video of the speaker and slides is av...

By: InstaTapesMedia

Read the original:

Clinical Genetics and Epigenetics: Precision Medicine for Age Management by Florence Comite, MD - Video

News Express Sting Operation: Ayurvedic doctor’s Allopathy medicine to patients – Video


News Express Sting Operation: Ayurvedic doctor #39;s Allopathy medicine to patients
News Express Sting Operation: Ayurvedic doctor #39;s Allopathy medicine to patients. The clinic is based in Delhi #39;s Karolbagh. In the expose, it was found out th...

By: News Express

Read more here:

News Express Sting Operation: Ayurvedic doctor's Allopathy medicine to patients - Video

Magical Medicine for oboe clarinet bassoon tuba celesta violin composed by David Huang – Video


Magical Medicine for oboe clarinet bassoon tuba celesta violin composed by David Huang
This is a story about a witch cooking magical medicine. In this piece every instrument plays different roles. Violin as the witch clarinet as the bat oboe as...

By: David Huang

Read this article:

Magical Medicine for oboe clarinet bassoon tuba celesta violin composed by David Huang - Video

Northwestern Medicine debuts new prostate test, reducing need for invasive biopsies

PUBLIC RELEASE DATE:

26-Feb-2014

Contact: Bret Coons bcoons@nmh.org 312-926-2955 Northwestern Memorial Hospital

CHICAGO Northwestern Medicine is the first health care provider in the country to offer a new non-invasive blood test for prostate cancer that is nearly three times more accurate than the current standard prostate-specific antigen (PSA) blood test. Known as the Prostate Health Index (phi), the new test's accuracy will effectively remove the need for many men who test positive for elevated PSA levels to undergo a biopsy to achieve a reliable diagnosis.

According to the Centers for Disease Control and Prevention (CDC), prostate cancer is the most common type of non-skin cancer for men in America and is a leading cause of cancer death among men of all races. The most widely used screening test for prostate cancer is currently the PSA test, which measures the blood's level of PSA, a protein that is naturally produced by the prostate gland and is typically increased when cancer is present. While the PSA test is simple and non-invasive, its results can often indicate the possibility of prostate cancer when none is present.

"The PSA test is based on the fact that men with higher levels of the PSA protein are more likely to have prostate cancer," said William Catalona, MD, urologist at Northwestern Medicine and director of the Clinical Prostate Cancer Program at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. "The problem is that higher levels of PSA can also be caused by a benign enlargement or inflammation of the prostate, leading to many false-positives for cancer and ultimately unnecessarily invasive biopsies and an increased potential for patient harm."

In 2012, the U.S. Preventive Services Task Force called attention to the heightened risk of unnecessary patient harm caused by false-positives from PSA testing and released a recommendation calling for "a better test and better treatment options" for prostate cancer screening.

Because PSA testing isn't conclusive enough on its own, physicians normally advise men with increased PSA levels in the range of 4-10ng/mL to undergo a prostate biopsy. However, the phi test helps physicians distinguish prostate cancer from benign conditions by utilizing three different PSA markers (PSA, FreePSA and p2PSA) as part of a sophisticated algorithm to more reliably determine the probability of cancer in patients with elevated PSA levels. Because of the substantial increase in accuracy, results of a multi-center clinical study that Catalona led found a 31 percent reduction in unnecessary biopsies due to false-positives as a result of using the phi test.

In addition to being much more accurate and reducing the need for prostate biopsies, the new test also offers patients a screening option that still only requires a simple blood test. The phi test will become available to all healthcare providers within the first quarter of 2014, and was developed by Beckman Coulter and evaluated in a multi-center clinical research study lead by Catalona as the principal investigator.

###

More:

Northwestern Medicine debuts new prostate test, reducing need for invasive biopsies